These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 39382931)
1. Prognostic Relevance of Immunophenotyping in Adult Patients with Acute Leukemia in Turkey: A Single-Center Experience. Demirelce O; Orhan B; Sonmez D; Topac FH; Turk RI; Altindal S; Inal BB Clin Lab; 2024 Oct; 70(10):. PubMed ID: 39382931 [TBL] [Abstract][Full Text] [Related]
2. [Immunophenotype characteristics and prognosis of acute leukemia patients with cross expressing lymphoid and myeloid lineage associated antigens]. Jiang NG; Chen XM; Zhu HL; Zhong L; Zeng TT; Jia YQ Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Dec; 18(6):1405-9. PubMed ID: 21176339 [TBL] [Abstract][Full Text] [Related]
3. Clinical and hematological correlates of aberrant immunophenotypic profiles in adult and pediatric acute myeloid leukemia at presentation. Sharma M; Varma N; Singh Sachdeva MU; Bose P; Varma S J Cancer Res Ther; 2020; 16(1):105-109. PubMed ID: 32362618 [TBL] [Abstract][Full Text] [Related]
4. [Immunophenotyping of 106 adult patients with acute leukemia by flow cytometry]. Xu B; Hu C; Miao XD; Wu YH; Yi ZS; Yang Y; Meng FY; Feng R; Liu QF; Liu XL; Zheng WY Di Yi Jun Yi Da Xue Xue Bao; 2003 Oct; 23(10):1043-6. PubMed ID: 14559689 [TBL] [Abstract][Full Text] [Related]
5. [Clinical study on prognosis of acute leukemia subtypes Ly + AML and My + ALL]. Liu B; Li R; Wu HJ; Chen Y Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Apr; 15(2):421-4. PubMed ID: 17493361 [TBL] [Abstract][Full Text] [Related]
6. Relevance of immunophenotypes to prognostic subgroups of age, WBC, platelet count, and cytogenetics in de novo acute myeloid leukemia. Li X; Li J; Du W; Zhang J; Liu W; Chen X; Li H; Huang S; Li X APMIS; 2011 Jan; 119(1):76-84. PubMed ID: 21143529 [TBL] [Abstract][Full Text] [Related]
7. Prognostic value of immunophenotyping in elderly patients with acute myeloid leukemia: a single-institution experience. Plesa C; Chelghoum Y; Plesa A; Elhamri M; Tigaud I; Michallet M; Dumontet C; Thomas X Cancer; 2008 Feb; 112(3):572-80. PubMed ID: 18085638 [TBL] [Abstract][Full Text] [Related]
8. [Immunologic characteristics and prognosis of acute myeloid leukemia M1]. Zhao F; Chen Y Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Aug; 15(4):687-91. PubMed ID: 17708783 [TBL] [Abstract][Full Text] [Related]
9. Clinical significance of co-expression of aberrant antigens in acute leukemia: a retrospective cohort study in Makah Al Mukaramah, Saudi Arabia. Abdulateef NA; Ismail MM; Aljedani H Asian Pac J Cancer Prev; 2014; 15(1):221-7. PubMed ID: 24528030 [TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of CD56 antigen expression in acute myeloid leukemia. Di Bona E; Sartori R; Zambello R; Guercini N; Madeo D; Rodeghiero F Haematologica; 2002 Mar; 87(3):250-6. PubMed ID: 11869936 [TBL] [Abstract][Full Text] [Related]
11. Clinical aspects of infant leukemia--experiences of a single institution of Japan: high level of serum immunoglobulin M in infant leukemia. Maeda M; Fukunaga Y; Asano T; Migita M; Ueda T; Hamada H; Hayakawa J; Narazaki H; Kaizu K J Nippon Med Sch; 2005 Dec; 72(6):355-63. PubMed ID: 16415515 [TBL] [Abstract][Full Text] [Related]
12. Morphologic dysplasia in de novo acute myeloid leukemia (AML) is related to unfavorable cytogenetics but has no independent prognostic relevance under the conditions of intensive induction therapy: results of a multiparameter analysis from the German AML Cooperative Group studies. Haferlach T; Schoch C; Löffler H; Gassmann W; Kern W; Schnittger S; Fonatsch C; Ludwig WD; Wuchter C; Schlegelberger B; Staib P; Reichle A; Kubica U; Eimermacher H; Balleisen L; Grüneisen A; Haase D; Aul C; Karow J; Lengfelder E; Wörmann B; Heinecke A; Sauerland MC; Büchner T; Hiddemann W J Clin Oncol; 2003 Jan; 21(2):256-65. PubMed ID: 12525517 [TBL] [Abstract][Full Text] [Related]
13. [Biological properties and sensitivity to induction therapy of differentiated cells expressing atypical immunophenotype in acute leukemia of children]. Pituch-Noworolska A Folia Med Cracov; 2001; 42(3):5-80. PubMed ID: 12353422 [TBL] [Abstract][Full Text] [Related]
14. CD34 expression predicts an adverse outcome in patients with NPM1-positive acute myeloid leukemia. Dang H; Chen Y; Kamel-Reid S; Brandwein J; Chang H Hum Pathol; 2013 Oct; 44(10):2038-46. PubMed ID: 23701943 [TBL] [Abstract][Full Text] [Related]
15. The Incidence and Immunophenotypic and Genetic Features of JL1 Expressing Cells and the Therapeutic Potential of an Anti-JL1 Antibody in Park SH; You E; Park CJ; Jang S; Cho YU; Yoon CH; Koh KN; Im HJ; Seo JJ Ann Lab Med; 2019 Jul; 39(4):358-366. PubMed ID: 30809981 [TBL] [Abstract][Full Text] [Related]
16. [The features and significance of immunophenotyping in adult acute leukemia]. Pei MF; Zhang GS; Xiao L Hunan Yi Ke Da Xue Xue Bao; 2000 Jun; 25(3):262-4. PubMed ID: 12212161 [TBL] [Abstract][Full Text] [Related]
17. Haematologic and immunophenotypic profile of acute myeloid leukemia: an experience of Tata Memorial Hospital. Ghosh S; Shinde SC; Kumaran GS; Sapre RS; Dhond SR; Badrinath Y; Ansari R; Kumar A; Mahadik S; Chougule AB; Nair CN Indian J Cancer; 2003; 40(2):71-6. PubMed ID: 14716122 [TBL] [Abstract][Full Text] [Related]
18. Immunological classification of acute myeloblastic leukemias: relevance to patient outcome. Casasnovas RO; Slimane FK; Garand R; Faure GC; Campos L; Deneys V; Bernier M; Falkenrodt A; Lecalvez G; Maynadié M; Béné MC Leukemia; 2003 Mar; 17(3):515-27. PubMed ID: 12646939 [TBL] [Abstract][Full Text] [Related]
19. Clinicopathological Evaluation of Acute Leukemias in a Tertiary Care Hospital: A Cross-Sectional Study. Patel GN; Gudur R; Gudur A; Oswal RM; Kanethkar S Turk Patoloji Derg; 2021; 37(2):145-153. PubMed ID: 33973643 [TBL] [Abstract][Full Text] [Related]
20. The imbalanced profile and clinical significance of T helper associated cytokines in bone marrow microenvironment of the patients with acute myeloid leukemia. Sun YX; Kong HL; Liu CF; Yu S; Tian T; Ma DX; Ji CY Hum Immunol; 2014 Feb; 75(2):113-8. PubMed ID: 24269703 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]